RSS Marijuana Investing News
  • Marijuana News Is Moving December 19, 2018
    News content on is being reborn as Weedmaps News at While our URL has changed, you can still find breaking news, political coverage, science explainers, and deep dives into the culture of cannabis. The archives remain available, with the exception of recent selections that have transferred to Weedmaps News. While won’t […]
    Nicolas Juarez
  • Rights Groups, Unions Call for Ending Marijuana Prohibition December 14, 2018
    A coalition of major civil rights organizations, labor unions and other groups is calling on Congress to completely remove marijuana from the Controlled Substances Act and divert revenue to communities that have been harmed by the enforcement of cannabis prohibition.   “Pass legislation de-scheduling marijuana with racial equity and justice reform components,” reads one recommendation […]
    Marijuana Moment
  • How Trump Government Shutdown Threat Could Affect Marijuana December 13, 2018
    President Donald Trump is threatening to shut down the government if Democrats refuse billions of dollars in funding for a border wall — but the consequences of that action would extend far beyond border security. WASHINGTON (AP) — Trump threatens gov't shutdown in heated meeting with Dem leaders over border wall, squabbling over election results. […]
    Marijuana Moment
  • Elon Musk Confesses: ‘I Have No Idea How To Smoke Pot’ December 12, 2018
    Elon Musk got himself into a bit of trouble after smoking marijuana during an appearance on Joe Rogan’s podcast in September 2018. The move reportedly led to NASA launching an investigation into his company SpaceX’s “workplace safety” and “adherence to a drug-free environment.” But now, in a new interview 60 Minutes, the Tesla founder indicated […]
    Marijuana Moment
  • Cannabis May Qualify for Study Grants as ‘Natural Product’ December 11, 2018
    Federally funded research into marijuana seems to be escalating, with one government agency recently posting a roundup of current “cannabinoid-related funding opportunities” for studies investigating the plant’s therapeutic potential. The National Center for Complementary and Integrative Health (NCCIH) on Dec. 8, 2018, shared a list of four research grant opportunities for studies on “natural products” […]
    Marijuana Moment
  • Surgeon General: Schedule I Hinders Researching Marijuana December 7, 2018
    U.S. Surgeon General Jerome Adams said the federal government should rethink how it classifies drugs like marijuana Dec. 6, 2018, voicing concern that the plant’s current status as a strictly controlled Schedule I substance inhibits research. Adams, who’s previously expressed interest in expanding research into the use of cannabinoids for therapeutic purposes, made the comment […]
    Marijuana Moment
  • Colorado County Considers Canceling Cannabis Convictions December 6, 2018
    BOULDER, Colo. (AP) — Prosecutors in a Colorado county are preparing to dismiss and seal thousands of marijuana possession convictions after state voters legalized the use and sale of cannabis in 2012. The Boulder Daily Camera reported that the Boulder County District Attorney’s Office as part of a “Moving on from Marijuana” program has identified […]
    Associated Press
  • GOP House Leader Calling for Legal Marijuana in Rhode Island December 5, 2018
    The Republican leader in Rhode Island’s House of Representatives thinks the state should fully legalize marijuana. But while that news would typically bode well for reform efforts in state legislatures, the problem is that the Democratic speaker isn’t quite on board — and the House is dominantly controlled by Democrats. In an interview with Rhode […]
    Marijuana Moment
  • ‘Compromise’ Medical Marijuana Bill is Made Into Law in Utah December 4, 2018
    Utah lawmakers approved a controversial medical marijuana bill in a special session Dec. 3, 2018. There’s your final vote on the medical marijuana “compromise.” #utpol — Robert Gehrke (@RobertGehrke) December 3, 2018 During the Nov. 6, 2018, election, Utah voters passed a separate medical cannabis initiative, Proposition 2, that would allow patients with certain […]
    Marijuana Moment
  • Study: Vaporizing Flower Produces A More Intense High Than Traditional Smoking Methods December 4, 2018
    Vaping marijuana flower gets you higher than smoking it, according to a new study published in an American Medical Association journal. To test the difference, researchers started by recruiting 17 people who’d consumed cannabis in the past year but had abstained for at least one month. Each individual participated in six sessions that lasted 8 1/2 […]
    Marijuana Moment
mentor36 May 22, 2019

Danish Health Minister Ellen Trane Nørby addresses a packed house at the European Cannabis Symposium in Copenhagen last week.

Inconsistent regulations for medical marijuana across Europe create an uneven playing field that makes doing business and accessing medicine cumbersome, according to Danish Health Minister Ellen Trane Nørby.

In an interview with Marijuana Business Daily on the sidelines of the European Cannabis Symposium in Copenhagen, Nørby said regulations and legislation for medical marijuana in Denmark and across Europe should be streamlined for the benefit of patients and businesses.

Changes are already in the works in the respective Danish and European parliaments.

“In Denmark, we have to look into the cultivation program in order to ensure that the conditions for cultivation are positive. We can see that there are challenges in different parts in the cultivation process where we simply need clarity,” she said.

“We have already changed the legislation twice, in order to allow bulk exports. We didn’t foresee that in the beginning.”

One change around the corner is a sunset clause that will terminate the ability of Canadian producers to export medical cannabis into Denmark with Canadian-approved pesticides.

Medical marijuana products imported into Denmark will also need to be produced at an EU-Good Manufacturing Practice-certified location, something not currently required.

Danish and international companies expect to start shipping locally produced medical cannabis in the coming months, which will increase product supply and lower prices – and ultimately will be a boon for the local market.

“We believe that within hopefully a few months or half a year, we’ll have Danish products also on the shelves,” Nørby said. “We do think there will be much more competition, which will drive down prices, and then there will be a greater number of products to choose from.

“The way to move forward for Denmark is to provide businesses with good conditions to participate in the scheme.”

Through the end of April, 2,104 individual patients had been prescribed medical cannabis since the program was launched in January 2018, much higher than the 500 patients that the Danish Medicines Authority originally expected to participate in the program.

Another 335 non-Danish patients – mostly Swedes – also accessed medical marijuana in Denmark during that period.

The country’s four-year pilot program was initiated in 2018 and expires in 2022. It will be evaluated in 2020 and at its conclusion in 2022.


Nørby also would like to see clarity and consistency on regulations and laws related to medical CBD across the European Union.

Denmark has asked all European countries to provide their legislation and regulations related to the cannabinoid, but many countries so far failed to answer the request.

“And the thing is, we have a free internal market in the EU. But we can see that many European countries have CBD oils on pharmacy shelves, but they do not have legislation,” Nørby said.

“If you have countries that do not have legislation – or just do not follow the legislation that they have in the country – you put patients and you put producers and consumers in a very difficult situation.”

In February, the World Health Organization (WHO) recommended that pure CBD and CBD preparations containing no more than 0.2% THC not be included in any way in the international drug control conventions.

The United Nations Commission on Narcotic Drugs did not vote on the WHO recommendations at its March session in Vienna – leaving it for possible consideration at its next meeting.

Matt Lamers can be reached at [email protected]
Matt Lamers can be reached at [email protected]

© 2018 Highline Media Group